Former Teva CEO Eli Hurvitz was hospitalized on Monday at the Sheba Medical Center in Tel Hashomer in a serious condition. The reason for his hospitalization was not immediately clear, and both Teva and Hurvitz's family refused to comment to the media. Hurvitz, 79, is considered to be primarily responsible for the pharmaceutical giant's global success. Since retiring from Teva last year, he has continued to play an active role in different research projects, and recently received a number of lifetime achievement awards. Hurvitz was awarded the Go4Europe Achievement Prize at the 2011 Go4Europe conference, organized to address fund-raising issues and efforts to establish strategic alliances in Europe. The Ariel Academic College in Samaria awarded him a prize for his contributions to the high-tech industry and the Israeli economy. Nine years ago, Hurvitz was awarded the Israel Prize. He has since received honorary doctorates from a number of institutions of higher learning in Israel. Hurvitz was CEO of Teva from 1976 to 2002 and then chairman of the board from 2002 to 2010. In addition to his roles at Teva, he was president of the Manufacturers' Association of Israel from 1981 to 1986, and was also director of the board at Bank Leumi in the mid-1980s. Hurvitz was urged on many occasions, to run for public office or become involved in Israeli politics, but always refused, preferring to remain in the world of business management.
Former Teva CEO hospitalized in serious condition
Eli Hurvitz reported in serious but stable condition on Tuesday • Hurvitz is considered responsible for Teva's international success • He is known as a leader in his field and has received a number of prestigious awards, including the Israel Prize.
Load more...